Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eli Lilly | Vienna | Healthcare | Pharmaceuticals | EUR 636.14B | 78.8x | 1.16 | EUR 718.50 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Johnson & Johnson | Vienna | Healthcare | Pharmaceuticals | EUR 344.61B | 24.1x | -0.44 | EUR 142.88 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Novo Nordisk AS | Vienna | Healthcare | Pharmaceuticals | EUR 342.51B | 27.4x | 1.01 | EUR 77.01 | -4.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abbvie | Vienna | Healthcare | Pharmaceuticals | EUR 295.14B | 59.9x | -2.78 | EUR 167.70 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Merck & Co | Vienna | Healthcare | Pharmaceuticals | EUR 241.14B | 20.5x | 0.12 | EUR 98.80 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AstraZeneca DRC | Vienna | Healthcare | Pharmaceuticals | EUR 200.82B | 31.9x | 3.25 | EUR 66 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pfizer | Vienna | Healthcare | Pharmaceuticals | EUR 145.09B | 35x | -0.59 | EUR 25.57 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Amgen | Vienna | Healthcare | Pharmaceuticals | EUR 142.39B | 34.6x | -0.78 | EUR 262.25 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sanofi | Vienna | Healthcare | Pharmaceuticals | EUR 122.52B | 25.5x | -0.54 | EUR 98.36 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Gilead Sciences | Vienna | Healthcare | Pharmaceuticals | EUR 111.42B | 913.6x | -9.28 | EUR 89.76 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bristol Myers Squibb | Vienna | Healthcare | Pharmaceuticals | EUR 111.14B | -15.8x | 0.08 | EUR 54 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Zoetis | Vienna | Healthcare | Pharmaceuticals | EUR 72.86B | 31.3x | 3.68 | EUR 163.88 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Merck KGaA | Vienna | Healthcare | Pharmaceuticals | EUR 61.46B | 22.8x | -3.24 | EUR 142.35 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Takeda Pharmaceutical | Vienna | Healthcare | Pharmaceuticals | EUR 39.87B | 21.9x | 0.44 | EUR 25.24 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ucb SA | Vienna | Healthcare | Pharmaceuticals | EUR 34.62B | 144.4x | -5.22 | EUR 185.45 | -3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Teva Pharmaceutical Industries DRC | Vienna | Healthcare | Pharmaceuticals | EUR 24.60B | -26.1x | -0.44 | EUR 21.20 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bayer | Vienna | Healthcare | Pharmaceuticals | EUR 20.77B | -23.6x | EUR 21.12 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Biogen Inc | Vienna | Healthcare | Pharmaceuticals | EUR 19.94B | 12.7x | 1.26 | EUR 136.25 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Viatris | Vienna | Healthcare | Pharmaceuticals | EUR 13.13B | -15.4x | 0.1 | EUR 11.06 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biomarin Pharma | Vienna | Healthcare | Pharmaceuticals | EUR 11.42B | 36.3x | 0.31 | EUR 59.72 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Recordati Industria Chimica e | Vienna | Healthcare | Pharmaceuticals | EUR 11.23B | 27.1x | 2.09 | EUR 54.75 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ipsen | Vienna | Healthcare | Pharmaceuticals | EUR 10.15B | 15x | 0.3 | EUR 123.80 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Grifols | Vienna | Healthcare | Pharmaceuticals | EUR 5.56B | 37.4x | EUR 8.94 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
H Lundbeck AS | Vienna | Healthcare | Pharmaceuticals | EUR 5.14B | 15.4x | 1.54 | EUR 5.40 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
H Lundbeck AS | Vienna | Healthcare | Pharmaceuticals | EUR 5.14B | 15.4x | 1.54 | EUR 4.35 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Laboratorios Farmaceuticos ROVI | Vienna | Healthcare | Pharmaceuticals | EUR 3.08B | 19.6x | EUR 60.75 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Dermapharm Holding SE | Vienna | Healthcare | Pharmaceuticals | EUR 2.17B | 24x | -4.98 | EUR 40.40 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bavarian Nordic AS | Vienna | Healthcare | Pharmaceuticals | EUR 2.07B | 13.7x | 0.28 | EUR 26.18 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Almirall | Vienna | Healthcare | Pharmaceuticals | EUR 1.86B | -41.5x | EUR 8.74 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Biotest Pref | Vienna | Healthcare | Pharmaceuticals | EUR 1.37B | 24.3x | -0.84 | EUR 27.50 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |